Analysis and optimization of interactions between peptides mimicking the GD2 ganglioside and the monoclonal antibody 14G2a

International Journal of Molecular Medicine

Volumn 28, Issue 1, 2011, Pages 47-57

  Horwacik, Irena ^a   Kurciński, Mateusz ^b   Bzowska, Małgorzata ^a   Kowalczyk, Aleksandra K ^a   Czaplicki, Dominik ^a   Koliński, Andrzej ^b   Rokita, Hanna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cancer; Carbohydrate mimicking peptide; GD2 ganglioside; Neuroblastoma

Indexed keywords

ARGINYLCYSTEINYLASPARAGINYLPROLYLASPARAGINYLMETHIONYLGLUTAMYLPROLYLPROLYLARGINYL CYSTEINYLPHENYLALANINE; ASPARAGINYLCYSTEINYLASPARTYLLEUCYLLEUCYLTHREONYLGLYCYLPROLYLMETHIONYLLEUCYLCYSTE INYLVALINE; DISULFIDE; GANGLIOSIDE GD2; GLYCYLCYSTEINYLASPARTYLALANYLLEUCYLSERYLGLYCYLHISTIDYLLEUCYLLEUCYLCYSTEINYLSERIN E; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 14G2A; PEPTIDOMIMETIC AGENT; PROTEIN P8; SERYLCYSTEINYLGLUTAMINYLSERYLTHREONYLARGINYLMETHIONYLASPARTYLPROLYLASPARAGINYLCY STEINYLTRYPTOPHAN; UNCLASSIFIED DRUG; VALYLCYSTEINYLASPARAGINYLPROLYLLEUCYLTHREONYLGLYCYLALANYLLEUCYLLEUCYLCYSTEINYLSE RINE;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG BINDING; DRUG STRUCTURE; HUMAN; HUMAN CELL; MOLECULAR MIMICRY; MOLECULAR MODEL; NEUROBLASTOMA CELL; PHAGE DISPLAY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BINDING SITES; CELL LINE, TUMOR; GANGLIOSIDES; HUMANS; MODELS, MOLECULAR; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; PEPTIDE LIBRARY; PEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79955823590     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.655     Document Type: Article

References (44)

1. Smith GP and Petrenko VA: Phage display. Chem Rev 97: 391-410, 1997. (Pubitemid 127659250)
2. Beenhouwer DO, May RJ, Valadon P and Scharff MD: High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library. J Immunol 169: 6992-6999, 2002. (Pubitemid 36899287)
3. Torregrossa P, Buhl L, Bancila M, Durbec P, Schafer C, Schachner M and Rougon G: Selection of poly-alpha 2,8-sialic acid mimotopes from a random phage peptide library and analysis of their bioactivity. J Biol Chem 279: 30707-30714, 2004.
4. Fleuridor R, Lyles RH and Pirofski L: Quantitative and qualitative differences in the serum antibody profiles of human immuno-deficiency virus-infected persons with and without Cryptococcus neoformans meningitis. J Infect Dis 180: 1526-1535, 1999. (Pubitemid 29506454)
5. Lucas AH, Rittenhouse-Olson K, Kronenberg M, Apicella MA, Wang D, Schreiber JR and Taylor CE: Carbohydrate moieties as vaccine candidates: meeting summary. Vaccine 28: 1121-1131, 2010.
6. Valadon P, Nussbaum G, Oh J and Scharff MD: Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide. J Immunol 161: 1829-1836, 1998.
7. Cunto-Amesty G, Luo P, Monzavi-Karbassi B, Lees A and Kieber-Emmons T: Exploiting molecular mimicry to broaden the immune response to carbohydrate antigens for vaccine development. Vaccine 19: 2361-2368, 2001. (Pubitemid 32234241)
8. Shin JS, Lin JS, Anderson PW, Insel RA and Nahm MH: Monoclonal antibodies specific for Neisseria meningitidis group B polysaccharide and their peptide mimotopes. Infect Immun 69: 3335-3342, 2001. (Pubitemid 32332232)
9. Yoshida S, Fukumoto S, Kawaguchi H, Sato S, Ueda R and Furukawa K: Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. Cancer Res 61: 4244-4252, 2001. (Pubitemid 32720995)
10. Hettmer S, Ladisch S and Kaucic K: Low complex ganglioside expression characterizes human neuroblastoma cell lines. Cancer Lett 225: 141-149, 2005. (Pubitemid 40732777)
11. Ravindranath MH, Muthugounder S and Presser N: Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient. Melanoma Res 18: 47-55, 2008. (Pubitemid 351628056)
12. Cheung NK, Lazarus H, Miraldi FD, Abramowsky CR, Kallick S, Saarinen UM, Spitzer T, Strandjord SE, Coccia PF and Berger NA: Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 5: 1430-1440, 1987. (Pubitemid 18049879)
13. Kawashima I, Tada N, Fujimori T and Tai T: Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro. J Biochem 108: 109-115, 1990. (Pubitemid 20213426)
14. Choi BS, Sondel PM, Hank JA, Schalch H, Gan J, King DM, Kendra K, Mahvi D, Lee LY, Kim K and Albertini MR: Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma. Cancer Immunol Immunother 55: 761-774, 2006.
15. Modak S and Cheung NK: Neuroblastoma: therapeutic strategies for a clinical enigma. Cancer Treat Rev 36: 307-317, 2010.
16. Zeytin HE, Tripathi PK, Bhattacharya-Chatterjee M, Foon KA and Chatterjee SK: Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2. Cancer Gene Ther 7: 1426-1436, 2000.
17. Basak S, Birebent B, Purev E, Somasundaram R, Maruyama H, Zaloudik J, Swoboda R, Strittmatter W, Li W, Luckenbach A, Song H, Li J, Sproesser K, Guerry D, Nair S, Furukawa K and Herlyn D: Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside. Cancer Immunol Immunother 52: 145-154, 2003. (Pubitemid 36384714)
18. Bolesta E, Kowalczyk A, Wierzbicki A, Rotkiewicz P, Bambach B, Tsao CY, Horwacik I, Kolinski A, Rokita H, Brecher M, Wang X, Ferrone S and Kozbor D: DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses. Cancer Res 65: 3410-3418, 2005. (Pubitemid 40524627)
19. Fest S, Huebener N, Weixler S, Bleeke M, Zeng Y, Strandsby A, Volkmer-Engert R, Landgraf C, Gaedicke G, Riemer AB, Michalsky E, Jaeger IS, Preissner R, Förster-Wald E, Jensen-Jarolim E and Lode HN: Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastases. Cancer Res 66: 10567-10575, 2006. (Pubitemid 44799780)
20. Horwacik I, Czaplicki D, Talarek K, Kowalczyk A, Bolesta E, Kozbor D and Rokita H: Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library. Int J Mol Med 19: 829-839, 2007.
21. Mujoo K, Kipps TJ, Yang HM, Cheresh DA, Wargalla U, Sander DJ and Reisfeld RA: Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18. Cancer Res 49: 2857-2861, 1989. (Pubitemid 19148615)
22. + selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry. Eur J Cancer 33: 2024-2030, 1997.
23. Cheung NK, Kushner BH and Kramer K: Monoclonal antibody-based therapy of neuroblastoma. Hematol Oncol Clin North Am 15: 853-866, 2001. (Pubitemid 34026974)
24. Bonnycastle LL, Mehroke JS, Rashed M, Gong X and Scott JK: Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage. J Mol Biol 258: 747-762, 1996. (Pubitemid 26150878)
25. Menendez A, Bonnycastle LLC, Pan OCC and Scott JK: Screening peptide libraries. In: Phage display. A laboratory manual. 1st edition. Barbas CF, Burton DR, Scott JK and Silverman GJ (eds.) Cold Spring Harbor Laboratory Press, New York, pp17.8-17.11, 2001.
26. + T cells by monoclonal antibodies directed against the gp120 C1 or C4 region. Immunol Lett 63: 19-25, 1998.
27. Koliński A: Protein modeling and structure prediction with a reduced representation. Acta Biochim Pol 51: 349-371, 2004.
28. Kurciński M and Koliński A: Steps towards flexible docking: modeling of three-dimensional structures of the nuclear receptors bound with peptide ligands mimicking co-activators' sequences. J Steroid Biochem Mol Biol 103: 357-360, 2007.
29. Colnago LA, Valentine KG and Opella SJ: Dynamics of fd coat protein in the bacteriophage. Biochemistry 26: 847-854, 1987. (Pubitemid 17021065)
30. van Regenmortel MH: From absolute to exquisite specificity. Reflections on the fuzzy nature of species, specificity and antigenic sites. J Immunol Methods 216: 37-48, 1998.
31. Zwick MB, Bonnycastle LL, Noren KA, Venturini S, Leong E, Barbas CF III, Noren CJ and Scott JK: The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage libraries. Anal Biochem 264: 87-97, 1998. (Pubitemid 28493875)
32. Popkov M, Sidrac-Ghali S, Alakhov V and Mandeville R: Epitope-specific antibody response to HT-1080 fibrosarcoma cells by mimotope immunization. Clin Cancer Res 6: 3629-3635, 2000.
33. Venkatesh N, Im SH, Balass M, Fuchs S and Katchalski-Katzir E: Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide. Proc Natl Acad Sci USA 97: 761-766, 2000. (Pubitemid 30070383)
34. Pameijer CR, Navanjo A, Meechoovet B, Wagner JR, Aguilar B, Wright CL, Chang WC, Brown CE and Jensen MC: Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor. Cancer Gene Ther 14: 91-97, 2007. (Pubitemid 44952238)
35. Ferrer M and Harrison SC: Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries. J Virol 73: 5795-5802, 1999. (Pubitemid 29274866)
36. Harris SL, Craig L, Mehroke JS, Rashed M, Zwick MB, Kenar K, Toone EJ, Greenspan N, Auzanneau FI, Marino-Albernas JR, Pinto BM and Scott JK: Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies. Proc Natl Acad Sci USA 94: 2454-2459, 1997. (Pubitemid 27136896)
37. Wondimu A, Zhang T, Kieber-Emmons T, Gimotty P, Sproesser K, Somasundaram R, Ferrone S, Tsao CY and Herlyn D: Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice. Cancer Immunol Immunother 7: 1079-1089, 2008. (Pubitemid 351601492)
38. Tong W, Gagnon M, Sprules T, Gilbert M, Chowdhury S, Meerovitch K, Hansford K, Purisima EO, Blankenship JW, Cheung NK, Gehring K, Lubell WD and Saragovi HU: Small-molecule ligands of GD2 ganglioside, designed from NMR studies, exhibit induced-fit binding and bioactivity. Chem Biol 17: 183-194, 2010.
39. Ferrières G, Villard S, Pugnière M, Mani JC, Navarro-Teulon I, Rharbaoui F, Laune D, Loret E, Pau B and Granier C: Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display. Role of sequences flanking the binding motif. Eur J Biochem 267: 1819-1829, 2000.
40. Jung HH, Yi HJ, Lee SK, Lee JY, Jung HJ, Yang ST, Eu YJ, Im SH and Kim JI: Structural analysis of immunotherapeutic peptides for autoimmune Myasthenia gravis. Biochemistry 46: 14987-14995, 2007.
41. Malik P, Terry TD, Gowda LR, Langara A, Petukhov SA, Symmons MF, Welsh LC, Marvin DA and Perham RN: Role of capsid structure and membrane protein processing in determining the size and copy number of peptides displayed on the major coat protein of filamentous bacteriophage. J Mol Biol 260: 9-21, 1996. (Pubitemid 26241387)
42. Dorgham K, Dogan I, Bitton N, Parizot C, Cardona V, Debré P, Hartley O and Gorochov G: Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes. AIDS Res Hum Retroviruses 21: 82-92, 2005. (Pubitemid 40179804)
43. Johnson DL, Farrell FX, Barbone FP, McMahon FJ, Tullai J, Hoey K, Livnah O, Wrighton NC, Middleton SA, Loughney DA, Stura EA, Dower WJ, Mulcahy LS, Wilson IA and Jolliffe LK: Identification of a 13-amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry 37: 3699-3710, 1998. (Pubitemid 28162924)
44. Gomes P, Giralt E and Andreu D: Antigenicity modulation upon peptide cyclization: application to the GH loop of foot-and-mouth disease virus strain C1-Barcelona. Vaccine 19: 3459-3466, 2001. (Pubitemid 32710296)